Considering the impact of liraglutide on neutrophil activation and the critical roles of neutrophils in cancer prognosis [51], we further analyzed the important circulating molecules released by neutrophils, finding that liraglutide decreased NETs markers myeloperoxidase, elastase, and dsDNA in both tumor models. This evidence concerns the gene MPO and cancer.